New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

byMass General BrighamCredit: Unsplash/CC0 Public DomainEsophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20%. Although a precursor lesion to
World medicine December 13,2023
Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

byMass General BrighamCredit: Unsplash/CC0 Public DomainEsophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20%. Although a precursor lesion to
World medicine December 13,2023
AI-based marker for colon cancer can help improve quality of treatment

AI-based marker for colon cancer can help improve quality of treatment

by Oslo University HospitalCredit: Institute for Cancer Genetics and Informatics, Oslo University HospitalA Norwegian-led research group has developed a clinically useful prognostic marker using deep
World medicine December 13,2023
AI-based marker for colon cancer can help improve quality of treatment

AI-based marker for colon cancer can help improve quality of treatment

by Oslo University HospitalCredit: Institute for Cancer Genetics and Informatics, Oslo University HospitalA Norwegian-led research group has developed a clinically useful prognostic marker using deep
World medicine December 13,2023
Immune cell health discovery could optimise cancer therapies

Immune cell health discovery could optimise cancer therapies

byUniversity College LondonCredit: CC0 Public DomainScientists at UCL have discovered how immune cells, essential for tackling life-threatening infections and cancers, are able to 'recycle&#
World medicine December 13,2023
Immune cell health discovery could optimise cancer therapies

Immune cell health discovery could optimise cancer therapies

byUniversity College LondonCredit: CC0 Public DomainScientists at UCL have discovered how immune cells, essential for tackling life-threatening infections and cancers, are able to 'recycle&#
World medicine December 13,2023
New lung immuno-oncology therapeutic strategy identified

New lung immuno-oncology therapeutic strategy identified

byThe Mount Sinai HospitalDenoted in red, with tumor cells illuminated in green, TREM2 macrophages heavily infiltrate and occupy lung cancer lesions. Credit: Park et al.,Nature ImmunologyR
World medicine December 13,2023
New lung immuno-oncology therapeutic strategy identified

New lung immuno-oncology therapeutic strategy identified

byThe Mount Sinai HospitalDenoted in red, with tumor cells illuminated in green, TREM2 macrophages heavily infiltrate and occupy lung cancer lesions. Credit: Park et al.,Nature ImmunologyR
World medicine December 13,2023
Roll up your sleeve and donate blood for cancer patients

Roll up your sleeve and donate blood for cancer patients

Many people don't realize that cancer patients are in constant need of blood supplies.Chemotherapy and radiation treatments for cancer can damage the body's ability to producehealthy blo
World medicine December 13,2023
Roll up your sleeve and donate blood for cancer patients

Roll up your sleeve and donate blood for cancer patients

Many people don't realize that cancer patients are in constant need of blood supplies.Chemotherapy and radiation treatments for cancer can damage the body's ability to producehealthy blo
World medicine December 13,2023
Can a second opinion make a difference?

Can a second opinion make a difference?

by Kathy Katella,Yale UniversityCredit: CC0 Public DomainYour doctor may be the smartest, most compassionate, thoughtful person in the world—a leading specialist or someone you've trusted fo
World medicine December 13,2023
Can a second opinion make a difference?

Can a second opinion make a difference?

by Kathy Katella,Yale UniversityCredit: CC0 Public DomainYour doctor may be the smartest, most compassionate, thoughtful person in the world—a leading specialist or someone you've trusted fo
World medicine December 13,2023
Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

byUC DavisCredit: Pixabay/CC0 Public DomainPioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind o
World medicine December 13,2023
Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

Canine Tumor Genome Atlas will map DNA in pets to help people with cancer

byUC DavisCredit: Pixabay/CC0 Public DomainPioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind o
World medicine December 13,2023
Researchers identify novel protein to prevent neuropathy from chemotherapy

Researchers identify novel protein to prevent neuropathy from chemotherapy

by National University of Singapore, Yong Loo Lin School of MedicineCredit: CC0 Public DomainA team of researchers from the NUS Yong Loo Lin School of Medicine has identified a novel protein that woul
World medicine December 13,2023
Researchers identify novel protein to prevent neuropathy from chemotherapy

Researchers identify novel protein to prevent neuropathy from chemotherapy

by National University of Singapore, Yong Loo Lin School of MedicineCredit: CC0 Public DomainA team of researchers from the NUS Yong Loo Lin School of Medicine has identified a novel protein that woul
World medicine December 13,2023
Study examines genetic testing in diverse young breast cancer patients over a decade

Study examines genetic testing in diverse young breast cancer patients over a decade

byFlorida Atlantic UniversityCredit: CC0 Public DomainBreast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to pos
World medicine December 13,2023
Study examines genetic testing in diverse young breast cancer patients over a decade

Study examines genetic testing in diverse young breast cancer patients over a decade

byFlorida Atlantic UniversityCredit: CC0 Public DomainBreast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to pos
World medicine December 13,2023
Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

bySociety of Nuclear Medicine68Ga-ABY-025 PET/CT and18F-FDG PET/CT images at baseline with18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disea
World medicine December 13,2023
Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

bySociety of Nuclear Medicine68Ga-ABY-025 PET/CT and18F-FDG PET/CT images at baseline with18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disea
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com